Cargando…
Genome-Wide Association Study of Lp-PLA(2) Activity and Mass in the Framingham Heart Study
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a...
Autores principales: | Suchindran, Sunil, Rivedal, David, Guyton, John R., Milledge, Tom, Gao, Xiaoyi, Benjamin, Ashlee, Rowell, Jennifer, Ginsburg, Geoffrey S., McCarthy, Jeanette J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861686/ https://www.ncbi.nlm.nih.gov/pubmed/20442857 http://dx.doi.org/10.1371/journal.pgen.1000928 |
Ejemplares similares
-
Gene by Sex Interaction for Measures of Obesity in the Framingham Heart Study
por: Benjamin, Ashlee M., et al.
Publicado: (2011) -
Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study
por: Chiba-Falek, Ornit, et al.
Publicado: (2010) -
Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016) -
Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010) -
Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)